Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis.
about
Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytesDietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitisPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorIrritable bowel syndrome and diet.Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFκB signaling and macrophage migration.Curcumin modulates the immune response associated with LPS-induced periodontal disease in ratsEUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses.Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity.The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitisCurcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.A neutraceutical by design: the clinical application of curcumin in colonic inflammation and cancer.Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway.Toll-like receptors as therapeutic targets in gastrointestinal diseases.Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury.Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways.Nutritional considerations in pediatric inflammatory bowel disease.Therapeutic potential of curcumin in gastrointestinal diseases.Bone, inflammation, and inflammatory bowel disease.Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.Curcumin in inflammatory diseases.Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkersTherapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?Curcumin, an active component of turmeric (Curcuma longa), and its effects on health.FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis.Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function.Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.Curcumin protects against concanavalin A-induced hepatitis in mice through inhibiting the cytoplasmic translocation and expression of high mobility group box 1.Immunomodulatory effects of phytogenics in chickens and pigs.Enhanced mucosal healing with curcumin in animal oral ulcer model.CUEDC2 Protects Against Experimental Colitis and Suppresses Excessive Proliferation of Intestinal Mucosa.Standardized curcuminoid extract (Curcuma longa l.) decreases gene expression related to inflammation and interacts with associated microRNAs in human umbilical vein endothelial cells (HUVEC).Bisdemethoxycurcumin and Its Cyclized Pyrazole Analogue Differentially Disrupt Lipopolysaccharide Signalling in Human Monocyte-Derived Macrophages.Local administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal disease.Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndromeA Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS)
P2860
Q21994486-4D4DCCC3-C7D1-4587-8E13-A692ADF02D20Q27021100-FEE65144-1253-4904-9F29-87730397A37BQ27022976-1A91F752-09ED-4CBE-AE17-9B7CD8B4A2BBQ33726873-D9821DE3-6515-4ED3-9E37-8090170DD32DQ33769533-09960AB0-A459-4B51-88E4-DC42448DDE20Q34450324-51BB93EA-63FA-4E1B-8A14-D0770D85A3E6Q35093744-07672264-AA6F-4DFD-B5F4-E4886DABE6E5Q35854435-7DA6EF1C-B8B0-4EAB-8ABA-07BC6BBB6A0EQ36423494-AA8C4849-0AE9-433C-8378-9CD067AF816CQ36611102-2B032B5A-2E6B-4A96-812F-DB6B78650621Q37090949-33A1A005-02BE-4365-81ED-0E9961694962Q37288656-05024584-C6E1-4D3B-8C48-0EB4282FBADEQ37575684-84104AE1-3787-48CD-80A1-22B649530569Q37690323-9A54C680-0522-44DE-90DD-3FE47ADB3678Q37703098-77BF0B79-9D65-432B-9477-48015C81EADAQ37728519-F617BF50-2B48-4D1E-B6DB-62341E35D7D1Q37763081-10DADDFB-E636-45F1-822A-5AC51BD1F969Q37878888-58DE1798-0D44-4B62-B0EC-900A9C5AA728Q37936285-A7410DA2-69CA-45C2-A719-7D91D0D1CAADQ38029557-0ECD535D-EDFD-4C9B-ADFB-38B644E19E93Q38071037-D050865C-3A4B-4916-9254-851B94FDB280Q38081415-6962375C-A5E8-49DB-AEE3-7634DEDFD9F0Q38083084-96A113A3-4FB5-419C-96F2-BF033C70EDFBQ39069841-88E0C8D6-E9C0-43CC-B5BA-673CE6F22CEBQ39142731-968FF909-6B3D-4DA9-ABC0-E22EFACFDBD8Q40156995-6BD71642-E7CE-4016-A7DD-9D823F87450DQ41808688-A6F38EB3-04E3-45D3-B639-F4D11A068B19Q42943410-3BA6E6F1-738F-4834-B93D-CF6A49D040EFQ44591614-E48B6B4A-1B5A-4C92-92F4-6CAFD864E956Q47561739-7DDF5417-5571-4479-83A5-C4EA8D0FAAECQ53193474-1E7E18EB-1919-4917-8C86-8E76FEF921ABQ53422806-E190CC7D-2322-4012-A01C-0F160859DF8DQ54328135-C38FFD2B-180A-4F46-A082-6F1960EC7EB2Q54922051-F223F1DF-F163-40C3-BB16-589C92AD9C8CQ54963833-5836E75A-1DB5-4D3C-87E3-24C166A23D36Q58541822-47186F06-4D79-40D4-8205-A8AE41A40843Q58702100-B387124A-86FA-464C-940C-E805760B1402
P2860
Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@ast
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@en
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@nl
type
label
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@ast
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@en
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@nl
prefLabel
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@ast
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@en
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@nl
P2093
P921
P1476
Curcumin attenuates inflammati ...... eptor in experimental colitis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11010-008-9949-4
P577
2008-11-11T00:00:00Z
P6179
1036320092